This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Mechanism and aetiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

It is commonly taught that type I hypersensitivity reactions are caused by the interaction of mast cell-bound IgE with allergen molecules. The resulting mast cell degranulation releases inflammatory mediators, including histamine and arachidonic acid metabolites.

Evidence for the role of IgE includes experiments in the mouse (the passive cutaneous anaphylaxis model) where IgE-containing serum may transfer allergen-specific hypersensitivity.

In contrast, recent research has demonstrated that genetically engineered mice, deficient in IgE, are susceptible to anaphylaxis. Other models of passive cutaneous anaphylaxis propose an alternative IgG-mediated pathway for type I hypersensitivity reactions.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.